PACIFIC BIOSCIENCES CALIF IN's ticker is PACB and the CUSIP is 69404D108. A total of 228 filers reported holding PACIFIC BIOSCIENCES CALIF IN in Q2 2022. The put-call ratio across all filers is 0.17 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,406,471 | -36.0% | 767,242 | +1.9% | 0.00% | -100.0% |
| Q2 2023 | $10,013,238 | -33.1% | 752,875 | -41.7% | 0.00% | 0.0% |
| Q1 2023 | $14,957,840 | +201.3% | 1,291,696 | +112.8% | 0.00% | – |
| Q4 2022 | $4,964,336 | +15.0% | 606,887 | -18.3% | 0.00% | -100.0% |
| Q3 2022 | $4,316,000 | +44.3% | 742,661 | +9.7% | 0.00% | – |
| Q2 2022 | $2,992,000 | +5.9% | 676,916 | +118.0% | 0.00% | – |
| Q1 2022 | $2,826,000 | -79.0% | 310,561 | -52.7% | 0.00% | – |
| Q4 2021 | $13,432,000 | +7.8% | 656,574 | +34.6% | 0.00% | -100.0% |
| Q3 2021 | $12,462,000 | -5.5% | 487,752 | +29.3% | 0.00% | -50.0% |
| Q2 2021 | $13,193,000 | -49.9% | 377,250 | -52.2% | 0.00% | -50.0% |
| Q1 2021 | $26,312,000 | -56.7% | 789,906 | -66.3% | 0.00% | -20.0% |
| Q4 2020 | $60,766,000 | +1349.6% | 2,342,554 | +451.7% | 0.01% | – |
| Q3 2020 | $4,192,000 | +697.0% | 424,628 | +178.0% | 0.00% | – |
| Q2 2020 | $526,000 | -12.3% | 152,732 | -22.1% | 0.00% | – |
| Q1 2020 | $600,000 | -19.7% | 195,958 | +34.9% | 0.00% | – |
| Q4 2019 | $747,000 | -27.3% | 145,287 | -27.1% | 0.00% | – |
| Q3 2019 | $1,028,000 | -56.3% | 199,219 | -48.8% | 0.00% | – |
| Q2 2019 | $2,354,000 | +282.8% | 389,466 | +358.2% | 0.00% | – |
| Q1 2019 | $615,000 | -29.8% | 85,000 | -28.2% | 0.00% | – |
| Q4 2018 | $876,000 | +49.7% | 118,372 | +9.4% | 0.00% | – |
| Q3 2018 | $585,000 | +119.9% | 108,205 | +44.5% | 0.00% | – |
| Q2 2018 | $266,000 | +111.1% | 74,900 | +21.4% | 0.00% | – |
| Q1 2018 | $126,000 | -79.9% | 61,700 | -74.0% | 0.00% | – |
| Q4 2017 | $626,000 | -30.8% | 237,081 | +37.7% | 0.00% | – |
| Q3 2017 | $904,000 | -11.6% | 172,229 | -40.1% | 0.00% | – |
| Q2 2017 | $1,023,000 | -65.5% | 287,306 | -50.0% | 0.00% | -100.0% |
| Q1 2017 | $2,969,000 | -5.4% | 574,481 | -30.4% | 0.00% | 0.0% |
| Q4 2016 | $3,137,000 | -49.6% | 825,566 | +18.8% | 0.00% | -50.0% |
| Q3 2016 | $6,227,000 | +0.1% | 694,926 | -21.4% | 0.00% | +33.3% |
| Q2 2016 | $6,218,000 | +50.4% | 883,994 | +81.8% | 0.00% | +50.0% |
| Q1 2016 | $4,133,000 | -21.2% | 486,159 | +21.7% | 0.00% | 0.0% |
| Q4 2015 | $5,244,000 | +1262.1% | 399,332 | +280.4% | 0.00% | – |
| Q3 2015 | $385,000 | -36.0% | 104,982 | +0.6% | 0.00% | – |
| Q2 2015 | $602,000 | +74.0% | 104,404 | +76.9% | 0.00% | – |
| Q1 2015 | $346,000 | -45.1% | 59,027 | -26.5% | 0.00% | – |
| Q4 2014 | $630,000 | +29.9% | 80,347 | -18.7% | 0.00% | – |
| Q3 2014 | $485,000 | -51.9% | 98,800 | -39.5% | 0.00% | – |
| Q2 2014 | $1,008,000 | +98.4% | 163,298 | +71.8% | 0.00% | – |
| Q1 2014 | $508,000 | +2.4% | 95,059 | +0.3% | 0.00% | – |
| Q4 2013 | $496,000 | -11.3% | 94,768 | -6.3% | 0.00% | – |
| Q3 2013 | $559,000 | +676.4% | 101,145 | +254.6% | 0.00% | – |
| Q2 2013 | $72,000 | – | 28,522 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 2,660,000 | $24,206,000 | 11.49% |
| Data Collective II GP, LLC | 164,249 | $1,495,000 | 5.44% |
| Decheng Capital Management III (Cayman), LLC | 1,463,872 | $13,321,000 | 4.08% |
| SB Management Ltd | 1,886,107 | $17,164,000 | 3.33% |
| Casdin Capital, LLC | 7,990,652 | $72,715,000 | 3.26% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,225,395 | $11,151,000 | 2.20% |
| Jackson Square Partners, LLC | 22,542,589 | $205,137,000 | 2.04% |
| BOURNE LENT ASSET MANAGEMENT INC | 556,865 | $5,067,000 | 1.59% |
| ARK Investment Management | 27,259,521 | $248,062,000 | 1.04% |
| Nikko Asset Management Americas, Inc. | 14,021,205 | $127,873,000 | 0.94% |